October 15, 2021

New U.S. Patent Approval for Episurf Medical

New U.S. Patent Approval for Episurf Medical
The patent is titled Determination and visualization of damage to an anatomical joint and relates to 3D-based assessment of joint lesions.
September 30, 2021

Study Results: Conformis iTotal CR Knee

Study Results: Conformis iTotal CR Knee
Review of 540 procedures revealed 98.5% implant survivorship and 89.0% patient satisfaction for the patient-specific iTotal CR device.
September 28, 2021

Episurf Developing MTP Joint Implant

Episurf Developing MTP Joint Implant
The company targets the filing of an FDA 510(k) application for the Episealer MTP system late 2022 or first half of 2023.

M&A | Partnerships

Products

October 15, 2021

New U.S. Patent Approval for Episurf Medical

New U.S. Patent Approval for Episurf Medical
The patent is titled Determination and visualization of damage to an anatomical joint and relates to 3D-based assessment of joint lesions.

Regulatory